Divergent developmental expression and function of the proton-coupled oligopeptide transporters PepT2 and PhT1 in regional brain slices of mouse and rat

Journal of Neurochemistry

Volumn 129, Issue 6, 2014, Pages 955-965

  Hu, Yongjun ^a   Xie, Yehua ^a   Keep, Richard F ^b   Smith, David E ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

brain; development; expression; function; PepT2; PhT1

Indexed keywords

CARRIER PROTEIN; GLYCYLSARCOSINE; HISTIDINE; PEPTIDE HISTIDINE TRANSPORTER 1; PEPTIDE HISTIDINE TRANSPORTER 2; PEPTIDE TRANSPORTER 1; PEPTIDE TRANSPORTER 2; UNCLASSIFIED DRUG;

ADULT; AGE; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN DEVELOPMENT; BRAIN SLICE; CEREBELLUM; CONTROLLED STUDY; GENE EXPRESSION; HIPPOCAMPUS; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SLC15 GENE;

MUS; RATTUS; RODENTIA;

BRAIN; DEVELOPMENT; EXPRESSION; FUNCTION; PEPT2; PHT1;

AGING; ANIMALS; ANIMALS, NEWBORN; BLOTTING, WESTERN; BRAIN; BRAIN CHEMISTRY; DIPEPTIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; FEMALE; HISTIDINE; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; SPECIES SPECIFICITY; SYMPORTERS;

EID: 84902385399     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12687     Document Type: Article

References (44)

1. Baccala R., Gonzalez-Quintial R., Blasius A. L., Rimann I., Ozato K., Kono D. H., Beutler B., and, Theofilopoulos A. N., (2013) Essential requirement for IRF8 and SLC15A4 implicates plasmacytoid dendritic cells in the pathogenesis of lupus. Proc. Natl Acad. Sci. USA 110, 2940-2945.
2. Brandsch M., Knutter I., and, Bosse-Doenecke E., (2008) Pharmaceutical and pharmacological importance of peptide transporters. J. Pharm. Pharmacol. 60, 543-585.
3. Daniel H., and, Kottra G., (2004) The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology. Pflugers Arch. 447, 610-618.
4. ε -AMCA in astrocytes. Glia 25, 10-20.
5. Dringen R., Hamprecht B., and, Bröer S., (1998) The peptide transporter PepT2 mediates the uptake of the glutathione precursor CysGly in astroglia-rich primary cultures. J. Neurochem. 71, 388-393.
6. +/peptide transporter PEPT2 mediated transport system. Neurosci. Lett. 271, 117-120.
7. +/peptide transporter PEPT2. Brain Res. 997, 52-61.
8. Groneberg D. A., Doring F., Eynott P. R., Fischer A., and, Daniel H., (2001) Intestinal peptide transport: ex vivo uptake studies and localization of peptide carrier PEPT1. Am. J. Physiol. Gastrointest. Liver Physiol. 281, G697-G704.
9. Haas H. L., Sergeeva O. A., and, Selbach O., (2008) Histamine in the nervous system. Physiol. Rev. 88, 1183-1241.
10. Han J.-W., Zheng H.-F., Cui Y., et al,. (2009) Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat. Genet. 41, 1234-1237.
11. He C. F., Liu Y. S., Cheng Y. L., et al,. (2010) TNIP1, SLC15A4, ETS1, RasGRP3 and IKZF1 are associated with clinical features of systemic lupus erythematosus in a Chinese Han population. Lupus 19, 1181-1186.
12. Herrera-Ruiz D., and, Knipp G. T., (2003) Current perspectives on established and putative mammalian oligopeptide transporters. J. Pharm. Sci. 92, 691-714.
13. Hough L. B., and, Leurs R., (2006) Histamine, in Basic Neurochemistry: Molecular, Cellular, and Medical Aspects (, Siegel G. J., Albers R. W., Brady S. T., and, Price D. L., eds), 7th edn, pp. 249-265. Elsevier, London.
14. Hu Y., Shen H., Keep R. F., and, Smith D. E., (2007) Peptide transporter 2 (PEPT2) expression in brain protects against 5-Aminolevulinic acid neurotoxicity. J. Neurochem. 103, 2058-2065.
15. Jappar D., Wu S. P., Hu Y., and, Smith D. E., (2010) Significance and regional dependency of peptide transporter (PEPT) 1 in the intestinal permeability of glycylsarcosine: in situ single-pass perfusion studies in wild-type and Pept1 knockout mice. Drug Metab. Dispos. 38, 1740-1746.
16. Jiang H., Hu Y., Keep R. F., and, Smith D. E., (2009) Enhanced antinociceptive response to intracerebroventricular kyotorphin in Pept2 null mice. J. Neurochem. 109, 1536-1543.
17. Kamal M. A., Keep R. F., and, Smith D. E., (2008) Role and relevance of PEPT2 in drug disposition, dynamics, and toxicity. Drug Metab. Pharmacokinet. 23, 236-242.
18. Keep R. F., and, Smith D. E., (2013) Oligopeptide and peptide-like drug transport, in The Handbook of Biologically Active Peptides, (, Kastin A. J., ed.), pp. 1688-1695. Elsevier, Burlington.
19. Lee J., Tattoli I., Wojtal K. A., Vavricka S. R., Philpott D. J., and, Girardin S. E., (2009) pH-dependent internalization of muramyl peptides from early endosomes enables Nod1 and Nod2 signaling. J. Biol. Chem. 284, 23818-23829.
20. Lee H. S., Kim T., Bang S. Y., et al,. (2013) Ethnic specificity of lupus-Associated loci identified in a genome-wide association study in Korean women. Ann. Rheum. Dis., doi: 10.1136/annrheumdis-2012-202675. [Epub ahead of print].
21. Martres M. P., Baudry M., and, Schwartz J. C., (1975) Histamine synthesis in the developing rat brain: evidence for a multiple compartmentation. Brain Res. 83, 261-275.
22. Nolan T., Hands R. E., and, Bustin S. A., (2006) Quantification of mRNA using real-time RT-PCR. Nat. Protoc. 1, 1559-1582.
23. Novotny A., Xiang J., Stummer W., Teuscher N. S., Smith D. E., and, Keep R. F., (2000) Mechanisms of 5-Aminolevulinic acid uptake at the choroid plexus. J. Neurochem. 75, 321-328.
24. Reid K. H., Edmonds H. L., Jr, Schurr A., Tseng M. T., and, West C. A., (1988) Pitfalls in the use of brain slices. Prog. Neurobiol. 31, 1-18.
25. Reiner P. B., Semba K., Fibiger H. C., and, McGeer E. G., (1988) Ontogeny of histidine-decarboxylase-immunoreactive neurons in the tuberomammillary nucleus of the rat hypothalamus: time of origin and development of transmitter phenotype. J. Comp. Neurol. 276, 304-311.
26. Rubio-Aliaga I., and, Daniel H., (2008) Peptide transporters and their roles in physiological processes and drug disposition. Xenobiotica 38, 1022-1042.
27. Sakata K., Yamashita T., Maeda M., Moriyama Y., Shimada S., and, Tohyama M., (2001) Cloning of a lymphatic peptide/histidine transporter. Biochem. J. 356, 53-60.
28. Sasawatari S., Okamura T., Kasumi E., Tanaka-Furuyama K., Yanobu-Takanashi R., Shirasawa S., Kato N., and, Toyama-Sorimachi N., (2011) The solute carrier family 15A4 regulates TLR9 and NOD1 functions in the innate immune system and promotes colitis in mice. Gastroenterology 140, 1513-1525.
29. Shen H., Smith D. E., Yang T., Huang Y. G., Schnermann J. B., and, Brosius F. C., 3rd, (1999) Localization of PEPT1 and PEPT2 proton-coupled oligopeptide transporter mRNA and protein in rat kidney. Am. J. Physiol. 276, F658-F665.
30. Shen H., Smith D. E., Keep R. F., Xiang J., and, Brosius F. C., 3rd, (2003) Targeted disruption of the PEPT2 gene markedly reduces dipeptide uptake in choroid plexus. J. Biol. Chem. 278, 4786-4791.
31. Shen H., Smith D. E., Keep R. F., and, Brosius F. C., 3rd, (2004) Immunolocalization of the proton-coupled oligopeptide transporter PEPT2 in developing rat brain. Mol. Pharm. 1, 248-256.
32. Shu C., Shen H., Teuscher N. S., Lorenzi P. J., Keep R. F., and, Smith D. E., (2002) Role of PEPT2 in peptide/mimetic trafficking at the blood-cerebrospinal fluid barrier: studies in rat choroid plexus epithelial cells in primary culture. J. Pharmacol. Exp. Ther. 301, 820-829.
33. Smith D. E., Johanson C. E., and, Keep R. F., (2004) Peptide and peptide analog transport systems at the blood-CSF barrier. Adv. Drug Deliv. Rev. 56, 1765-1791.
34. Smith D. E., Hu Y., Shen H., Nagaraja T. N., Fenstermacher J. D., and, Keep R. F., (2011) Distribution of glycylsarcosine and cefadroxil among cerebrospinal fluid, choroid plexus, and brain parenchyma after intracerebroventricular injection is markedly different between wild-type and Pept2 null mice. J. Cereb. Blood Flow Metab. 31, 250-261.
35. Smith D. E., Clémençon B., and, Hediger M. A., (2013) Proton-coupled oligopeptide transporter family SLC15: physiological, pharmacological and pathological implications. Mol. Aspects Med. 34, 323-336.
36. Subramanian N., Whitmore W. L., Seidler F. J., and, Slotkin T. A., (1981) Ontogeny of histaminergic neurotransmission in the rat brain: concomitant development of neuronal histamine, H-1 receptors, and H-1 receptor-mediated stimulation of phospholipid turnover. J. Neurochem. 36, 1137-1141.
37. Sun D., Wang Y., Tan F., Fang D., Hu Y., Smith D. E., and, Jiang H., (2013) Functional and molecular expression of the proton-coupled oligopeptide transporters in spleen and macrophages from mouse and human. Mol. Pharm. 10, 1409-1416.
38. Teuscher N. S., Novotny A., Keep R. F., and, Smith D. E., (2000) Functional evidence for presence of PEPT2 in rat choroid plexus: studies with glycylsarcosine. J. Pharmacol. Exp. Ther. 294, 494-499.
39. Teuscher N. S., Keep R. F., and, Smith D. E., (2001) PEPT2-mediated uptake of neuropeptides in rat choroid plexus. Pharm. Res. 18, 807-813.
40. Toledo A., Sabria J., Rodriguez R., Brandner R., Rodriguez J., Palacios J. M., and, Blanco I., (1988) Properties and ontogenic development of membrane-bound histidine decarboxylase from rat brain. J. Neurochem. 51, 1400-1406.
41. Tran V. T., Freeman A. D., Chang R. S., and, Snyder S. H., (1980) Ontogenetic development of histamine h1-receptor binding in rat brain. J. Neurochem. 34, 1609-1613.
42. Walker D., Thwaites D. T., Simmons N. L., Gilbert H. J., and, Hirst B. H., (1998) Substrate upregulation of the human small intestinal peptide transporter, hPepT1. J. Physiol. 507, 697-706.
43. Wang M., Zhang X., Zhao H., Wang Q., and, Pan Y., (2010) Comparative analysis of vertebrate PEPT1 and PEPT2 genes. Genetica 138, 587-599.
44. Yamashita T., Shimada S., Guo W., Sato K., Kohmura E., Hayakawa T., Takagi T., and, Tohyama M., (1997) Cloning and functional expression of a brain peptide/histidine transporter. J. Biol. Chem. 272, 10205-10211. Stroke